Artificial intelligence biosensors for continuous glucose monitoring

Abstract

Artificial intelligence (AI) algorithms in combination with continuous monitoring technologies have the potential to revolutionize chronic disease management. The recent innovations in both continuous glucose monitoring (CGM) and the closed-loop highlight the far-reaching potential of AI biosensors for individual healthcare. This review summarizes some of the most advanced progress made in CGM biosensing. We will focus on three main applications of AI algorithms in diabetes management: closed-loop control algorithms, glucose predictions, and calibrations. The challenges and opportunities of AI technologies for CGM in individualized and proactive medicine will also be discussed.